Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Dec 20;19(3):1878–1886. doi: 10.3892/etm.2019.8359

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Gong et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 6. — Treatment with the autophagy inhibitor, 3-MA, eliminates the protective properties of RV in malignancy. B16-F10 cells were treated with 100 µM RV with or without cotreatment with 10 mM 3-MA for 24 h. (A) Cell Counting Kit-8 assay was used to assess viability. (B) Percentage of apoptotic B16-F10 cells following the various treatments. (C) Annexin V-FITC/PI flow cytometry analysis of B16-F10 cells following RV, RV + 3-MA, or Con treatment. (D) Representative micrographs and (E) quantification of migratory B16-F10 cells in the lower chamber of the Transwell plates following treatment (magnification, ×20). Data are presented as the mean ± SEM. **P<0.01 vs. Con; ^#P<0.05 vs. RV. 3-MA, 3-methyladenine; PI, propidium iodide; RV, resveratrol.